291 related articles for article (PubMed ID: 21978933)
1. LPA receptor heterodimerizes with CD97 to amplify LPA-initiated RHO-dependent signaling and invasion in prostate cancer cells.
Ward Y; Lake R; Yin JJ; Heger CD; Raffeld M; Goldsmith PK; Merino M; Kelly K
Cancer Res; 2011 Dec; 71(23):7301-11. PubMed ID: 21978933
[TBL] [Abstract][Full Text] [Related]
2. CD97 amplifies LPA receptor signaling and promotes thyroid cancer progression in a mouse model.
Ward Y; Lake R; Martin PL; Killian K; Salerno P; Wang T; Meltzer P; Merino M; Cheng SY; Santoro M; Garcia-Rostan G; Kelly K
Oncogene; 2013 May; 32(22):2726-38. PubMed ID: 22797060
[TBL] [Abstract][Full Text] [Related]
3. Platelets Promote Metastasis via Binding Tumor CD97 Leading to Bidirectional Signaling that Coordinates Transendothelial Migration.
Ward Y; Lake R; Faraji F; Sperger J; Martin P; Gilliard C; Ku KP; Rodems T; Niles D; Tillman H; Yin J; Hunter K; Sowalsky AG; Lang J; Kelly K
Cell Rep; 2018 Apr; 23(3):808-822. PubMed ID: 29669286
[TBL] [Abstract][Full Text] [Related]
4. Lysophosphatidylethanolamine utilizes LPA(1) and CD97 in MDA-MB-231 breast cancer cells.
Park SJ; Lee KP; Kang S; Chung HY; Bae YS; Okajima F; Im DS
Cell Signal; 2013 Nov; 25(11):2147-54. PubMed ID: 23838008
[TBL] [Abstract][Full Text] [Related]
5. Mitogenic signaling by lysophosphatidic acid (LPA) involves Galpha12.
Radhika V; Hee Ha J; Jayaraman M; Tsim ST; Dhanasekaran N
Oncogene; 2005 Jun; 24(28):4597-603. PubMed ID: 15856019
[TBL] [Abstract][Full Text] [Related]
6. Lysophosphatidic acid activates the RhoA and NF-κB through Akt/IκBα signaling and promotes prostate cancer invasion and progression by enhancing functional invadopodia formation.
Hwang YS; Lee J; Zhang X; Lindholm PF
Tumour Biol; 2016 May; 37(5):6775-85. PubMed ID: 26662305
[TBL] [Abstract][Full Text] [Related]
7. The MLK-related kinase (MRK) is a novel RhoC effector that mediates lysophosphatidic acid (LPA)-stimulated tumor cell invasion.
Korkina O; Dong Z; Marullo A; Warshaw G; Symons M; Ruggieri R
J Biol Chem; 2013 Feb; 288(8):5364-73. PubMed ID: 23319595
[TBL] [Abstract][Full Text] [Related]
8. The gep proto-oncogene Gα12 mediates LPA-stimulated activation of CREB in ovarian cancer cells.
Ha JH; Ward JD; Varadarajalu L; Kim SG; Dhanasekaran DN
Cell Signal; 2014 Jan; 26(1):122-32. PubMed ID: 24055910
[TBL] [Abstract][Full Text] [Related]
9. LPA(4)/GPR23 is a lysophosphatidic acid (LPA) receptor utilizing G(s)-, G(q)/G(i)-mediated calcium signaling and G(12/13)-mediated Rho activation.
Lee CW; Rivera R; Dubin AE; Chun J
J Biol Chem; 2007 Feb; 282(7):4310-4317. PubMed ID: 17166850
[TBL] [Abstract][Full Text] [Related]
10. Lysophosphatidic acid induces prostate cancer PC3 cell migration via activation of LPA(1), p42 and p38alpha.
Hao F; Tan M; Xu X; Han J; Miller DD; Tigyi G; Cui MZ
Biochim Biophys Acta; 2007 Jul; 1771(7):883-92. PubMed ID: 17531530
[TBL] [Abstract][Full Text] [Related]
11. The G12/13-RhoA signaling pathway contributes to efficient lysophosphatidic acid-stimulated cell migration.
Bian D; Mahanivong C; Yu J; Frisch SM; Pan ZK; Ye RD; Huang S
Oncogene; 2006 Apr; 25(15):2234-44. PubMed ID: 16301993
[TBL] [Abstract][Full Text] [Related]
12. The gep proto-oncogene Gα13 mediates lysophosphatidic acid-mediated migration of pancreatic cancer cells.
Gardner JA; Ha JH; Jayaraman M; Dhanasekaran DN
Pancreas; 2013 Jul; 42(5):819-28. PubMed ID: 23508014
[TBL] [Abstract][Full Text] [Related]
13. The G-protein G13 but not G12 mediates signaling from lysophosphatidic acid receptor via epidermal growth factor receptor to Rho.
Gohla A; Harhammer R; Schultz G
J Biol Chem; 1998 Feb; 273(8):4653-9. PubMed ID: 9468525
[TBL] [Abstract][Full Text] [Related]
14. Glycogen synthase kinase-3 is activated in neuronal cells by Galpha12 and Galpha13 by Rho-independent and Rho-dependent mechanisms.
Sayas CL; Avila J; Wandosell F
J Neurosci; 2002 Aug; 22(16):6863-75. PubMed ID: 12177184
[TBL] [Abstract][Full Text] [Related]
15. Cooperation of G12/13 and Gi proteins via lysophosphatidic acid receptor-2 (LPA
Minami K; Ueda N; Ishimoto K; Kurisu R; Takamoto M; Ikeda H; Tsujiuchi T
Biochem Biophys Res Commun; 2020 Nov; 532(3):427-432. PubMed ID: 32883524
[TBL] [Abstract][Full Text] [Related]
16. A role for the G12 family of heterotrimeric G proteins in prostate cancer invasion.
Kelly P; Stemmle LN; Madden JF; Fields TA; Daaka Y; Casey PJ
J Biol Chem; 2006 Sep; 281(36):26483-90. PubMed ID: 16787920
[TBL] [Abstract][Full Text] [Related]
17. LPA receptor 1 mediates LPA-induced ovarian cancer metastasis: an in vitro and in vivo study.
Yu X; Zhang Y; Chen H
BMC Cancer; 2016 Nov; 16(1):846. PubMed ID: 27809800
[TBL] [Abstract][Full Text] [Related]
18. LPA1 receptors mediate stimulation, whereas LPA2 receptors mediate inhibition, of migration of pancreatic cancer cells in response to lysophosphatidic acid and malignant ascites.
Komachi M; Tomura H; Malchinkhuu E; Tobo M; Mogi C; Yamada T; Kimura T; Kuwabara A; Ohta H; Im DS; Kurose H; Takeyoshi I; Sato K; Okajima F
Carcinogenesis; 2009 Mar; 30(3):457-65. PubMed ID: 19129242
[TBL] [Abstract][Full Text] [Related]
19. MAGI-3 competes with NHERF-2 to negatively regulate LPA2 receptor signaling in colon cancer cells.
Lee SJ; Ritter SL; Zhang H; Shim H; Hall RA; Yun CC
Gastroenterology; 2011 Mar; 140(3):924-34. PubMed ID: 21134377
[TBL] [Abstract][Full Text] [Related]
20. Identification of heparin-binding EGF-like growth factor (HB-EGF) as a biomarker for lysophosphatidic acid receptor type 1 (LPA1) activation in human breast and prostate cancers.
David M; Sahay D; Mege F; Descotes F; Leblanc R; Ribeiro J; Clézardin P; Peyruchaud O
PLoS One; 2014; 9(5):e97771. PubMed ID: 24828490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
